CFTR and ENaC functions in cystic fibrosis

被引:0
|
作者
Palma, Alejandra G. [1 ]
Kotsias, Basilio A. [1 ]
Marino, Gabriela I. [1 ]
机构
[1] Univ Buenos Aires, IDIM CONICET, Inst Invest Med Alfredo Lanari, Lab Cana Ion, Buenos Aires, DF, Argentina
关键词
cystic fibrosis; CFTR; ENaC; ionic movements; cytoskeleton; TRANSMEMBRANE CONDUCTANCE REGULATOR; GAP-JUNCTION CHANNELS; MUTATIONS; GENE; EXPRESSION; DELTA-F508; TRANSPORT; AMILORIDE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cystic fibrosis is caused by dysfunction or lack of the cystic fibrosis transmembrane conductance regulator (CFTR), a chloride channel that has a key role in maintaining ion and water honnoeostasis in different tissues. CFTR is a cyclic AMP-activated Cl- channel found in the apical and basal plasma membrane of airway, intestinal, and exocrine epithelial cells. One of CFTR's primary roles in the lungs is to maintain homoeostasis of the airway surface liquid layer through its function as a chloride channel and its regulation of the epithelial sodium channel ENaC. More than 1900 CFTR mutations have been identified in the cftr gene. The disease is characterized by viscous secretions of the exocrine glands in multiple organs and elevated levels of sweat sodium chloride. In cystic fibrosis, salt and fluid absorption is prevented by the loss of CFTR and ENaC is not appropriately regulated, resulting in increased fluid and sodium resorption from the airways and formation of a contracted viscous surface liquid layer. In the sweat glands both Na+ and Cl- ions are retained in the lumen, causing significant loss of electrolytes during sweating. Thus, elevated sweat NaCl concentration is the basis of the classic pilocarpine-induced sweat test as a diagnostic feature of the disease. Here we discuss the ion movement of Cl- and Na+ ions in two tissues, sweat glands and in the air surface as well as the role of ENaC in the pathogenesis of cystic fibrosis.
引用
收藏
页码:133 / 139
页数:7
相关论文
共 50 条
  • [21] Cystic Fibrosis: CFTR Correctors to the Rescue
    Sheppard, David N.
    CHEMISTRY & BIOLOGY, 2011, 18 (02): : 145 - 147
  • [22] Cystic Fibrosis, CFTR, and Colorectal Cancer
    Scott, Patricia
    Anderson, Kyle
    Singhania, Mekhla
    Cormier, Robert
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (08)
  • [23] CFTR structure: lassoing cystic fibrosis
    Ford, Bob
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2017, 24 (01) : 13 - +
  • [24] CFTR Modulator Therapy for Cystic Fibrosis
    Grasemann, Hartmut
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (21): : 2085 - 2088
  • [25] Rewriting CFTR to cure cystic fibrosis
    Maule, Giulia
    Ensinck, Marjolein
    Bulcaen, Mattijs
    Carlon, Marianne S.
    CURING GENETIC DISEASES THROUGH GENOME REPROGRAMMING, 2021, 182 : 185 - 224
  • [26] CFTR, bicarbonate, and the pathophysiology of cystic fibrosis
    Borowitz, Drucy
    PEDIATRIC PULMONOLOGY, 2015, 50 : S24 - S30
  • [27] CFTR structure: lassoing cystic fibrosis
    Bob Ford
    Nature Structural & Molecular Biology, 2017, 24 : 13 - 14
  • [28] CFTR and pseudomonas infections in cystic fibrosis
    Tatterson, LE
    Poschet, JF
    Firoved, A
    Skidmore, J
    Deretic, V
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2001, 6 : D890 - D897
  • [29] CFTR Modulator Therapies for Cystic Fibrosis
    Trimble, Aaron T.
    Donaldson, Scott H.
    PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY, 2015, 28 (04) : 230 - 236
  • [30] CFTR Modulators for the Treatment of Cystic Fibrosis
    Hadida, Sabine
    Van Goor, Fredrick
    Grootenhuis, Peter D. J.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 45, 2010, 45 : 157 - 173